Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Ritlecitinib improves emotional well-being and activity levels in alopecia areata patients.

Sublingual minoxidil safely increases hair growth in transgender people on testosterone therapy.

New medications could improve treatment for severe alopecia areata in Australia.

Experts created guidelines for who in Australia can get subsidized JAK inhibitor therapy for alopecia areata.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

Horizant has risks like other seizure drugs, Johnson & Johnson misled about Risperdal, and Quanterix found a possible link between brain oxygen loss and Alzheimer's markers.

Proxalutamide significantly lowered hospital admissions for male COVID-19 patients compared to a placebo.

Ritlecitinib shows promise for treating alopecia areata, especially with early and extended treatment.

Alopecia areata significantly affects emotional well-being and daily activities, suggesting a need for patient-centered care.

Caregivers of teens with alopecia areata face significant mental and work-related challenges.

JAK inhibitors show promise for treating alopecia areata, but long-term safety and emotional support are important.

The analysis found that alopecia areata, a hair loss condition, is not very common in Australia, affecting about 0.13% of people, with new cases most often seen in males aged 19 to 34 years.

Gender-affirming hormone therapy changes hair growth in transgender people, with feminizing therapy reducing hair and masculinizing therapy increasing it, but sometimes additional treatment is needed.

Epidermal Wnt/β-catenin signaling controls fat cell formation and hair growth.

Hair specialists vary in testing for alopecia areata, highlighting the need for standard guidelines.

IFN-γ and IL-2 are important for T cell activation in hair loss in mice.

New treatments for alopecia areata show promise, but standardized guidelines are needed.

A woman with systemic sclerosis developed a unique scarring hair loss combining features of systemic sclerosis and frontal fibrosing alopecia.

Finasteride can cause serious emotional side effects; doctors should check patients' mental health history before prescribing.

Dexpanthenol improves hair growth and satisfaction in women without side effects.

PRP injections effectively improve stress urinary incontinence in women.

Some skin conditions are associated with other serious diseases, and office microscopy may miss many fungal infections.

Female pattern hair loss affects 32.3% of women, increasing with age and showing no racial differences.

Tofacitinib helped a teenager with severe hair loss grow hair back, but more research is needed.

Finasteride with oral contraceptive helps improve hair loss in premenopausal women.

Autoimmune diseases can cause hair loss, and early treatment is important to prevent permanent damage.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

Docetaxel chemotherapy causes more long-term hair loss and dissatisfaction than paclitaxel.